−83.8
Gyre Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
10.7
FY23:
25.9
FY24:
−3.64
FY25:
1.01
Change from FY21 to FY25
millions USD
FY21:
48.2
FY22:
−13.8
FY23:
−19.8
FY24:
−19.9
FY25:
−0.47
Change from FY21 to FY25
millions USD
FY21:
49.6
FY22:
−45.0
FY23:
2.50
FY24:
2.10
FY25:
24.4
millions USD
FY21:
14.0
FY22:
−5.03
FY23:
8.33
FY24:
−21.7
FY25:
25.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−84.6
FY22:
5.69
FY23:
17.4
FY24:
−5.96
FY25:
−0.18
All amounts in millions USD